Drug Interactions between bosutinib and COVID-19 mRNA (Moderna) vaccine
This report displays the potential drug interactions for the following 2 drugs:
- bosutinib
- COVID-19 mRNA (Moderna) vaccine
Interactions between your drugs
bosutinib SARS-CoV-2 (COVID-19) mRNA-LNP vaccine (cvx 311)
Applies to: bosutinib and COVID-19 mRNA (Moderna) vaccine
If you are currently being treated or have recently been treated with bosutinib, you should let your doctor know before receiving SARS-CoV-2 (COVID-19) mRNA-LNP vaccine (cvx 311). Depending on the dose and length of time you have been on bosutinib, you may have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of bosutinib therapy. If you have recently been vaccinated with SARS-CoV-2 (COVID-19) mRNA-LNP vaccine (cvx 311), your doctor may choose to postpone treatment with bosutinib for a couple of weeks or more. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
bosutinib food
Applies to: bosutinib
Bosutinib should be taken with a meal to help with its absorption. Do not consume grapefruit, grapefruit juice, or any supplements that contain grapefruit extract during treatment with bosutinib unless directed otherwise by your doctor. Grapefruit juice can significantly increase the blood levels of bosutinib. You may be more likely to experience side effects such as nausea, vomiting, abdominal pain, diarrhea, liver damage, and impaired bone marrow function resulting in low numbers of different types of blood cells, which can increase the risk of anemia, bleeding problems, and infections. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.